Syndax Pharmaceuticals (SNDX) PT Lowered to $20 at Citi; Reiterates Buy
Tweet Send to a Friend
Citi lowered its price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $20.00 (from $24.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
